Results 211 to 220 of about 48,196 (249)

Vasoactive Intestinal Peptide Tumor (VIPoma)

2021
Vasoactive intestinal peptide (VIP) is a neurotransmitter which is present in the neurons in the central nervous system, the lung, intestine, adrenals, pancreas, and liver and in neuroendocrine cells in the pancreas. In the gastrointestinal tract, VIP stimulates contraction of enteric smooth muscle cells, secretion from the exocrine pancreas ...
Zandee, Wouter T., Hofland, Johannes, de Herder, Wouter   +2 more
openaire   +1 more source

Vasoactive Intestinal Peptide

Regulatory Peptides, 1987
openaire   +2 more sources

Vasoactive intestinal peptides

General and Comparative Endocrinology, 1983
openaire   +1 more source

Vasoactive intestinal peptide

Trends in Pharmacological Sciences, 1982
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Vasoactive intestinal peptide

2016
openaire   +1 more source

Vasoactive Intestinal Peptide

2020
openaire   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly